ALLISON INSTITUTE Trademark

Trademark Overview


On Friday, March 25, 2022, a trademark application was filed for ALLISON INSTITUTE with the United States Patent and Trademark Office. The USPTO has given the ALLISON INSTITUTE trademark a serial number of 97975242. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Friday, May 9, 2025. This trademark is owned by The Board of Regents of the University of Texas System. The ALLISON INSTITUTE trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Charitable fundraising services

Promoting collaboration within the scientific, research, pharmaceutical, and medical communities to achieve advances in healthcare, including to accelerate the development and use of immunotherapy in treatment of disease

Medical services; Medical services relating to cancer; providing medical information; providing health information in the field of immunobiology, immunotherapy, oncology and diseases; providing a web site featuring medical information; providing a web site featuring health information in the field of immunobiology, immunotherapy, oncology and diseases; providing medical information, consultancy and advisory services; providing information on cancer treatment; providing medical information to patients and medical professionals in the field of immunotherapy and cancer treatment

Medical research services; medical research, development, technical design, testing, and analysis services in the field of immunobiology, immunotherapy, antibodies, and oncology; consulting services in the field of immunobiology, immunotherapy, antibodies, and oncology; medical research and development of antibodies, therapeutic products, vaccines, immunotherapy treatments and diagnostic products; medical research services in the field of immune repertoire analysis and the genome; scientific research in the fields of immunobiology, immunotherapy, antibodies and oncology; biological research; laboratory research services in the fields of immunobiology, immunotherapy, antibodies, oncology, and cellular engineering; medical laboratory services; providing information on medical and scientific research in the field of immunobiology and immunotherapy; medical and scientific research for others in the field of stem cell research, cancer, immunobiology and immunotherapy; compiling data for re...

General Information


Serial Number97975242
Word MarkALLISON INSTITUTE
Filing DateFriday, March 25, 2022
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateFriday, May 9, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 21, 2023

Trademark Statements


Goods and ServicesCharitable fundraising services
Goods and ServicesPromoting collaboration within the scientific, research, pharmaceutical, and medical communities to achieve advances in healthcare, including to accelerate the development and use of immunotherapy in treatment of disease
Goods and ServicesMedical services; Medical services relating to cancer; providing medical information; providing health information in the field of immunobiology, immunotherapy, oncology and diseases; providing a web site featuring medical information; providing a web site featuring health information in the field of immunobiology, immunotherapy, oncology and diseases; providing medical information, consultancy and advisory services; providing information on cancer treatment; providing medical information to patients and medical professionals in the field of immunotherapy and cancer treatment
NOT AVAILABLE"INSTITUTE"
Goods and ServicesMedical research services; medical research, development, technical design, testing, and analysis services in the field of immunobiology, immunotherapy, antibodies, and oncology; consulting services in the field of immunobiology, immunotherapy, antibodies, and oncology; medical research and development of antibodies, therapeutic products, vaccines, immunotherapy treatments and diagnostic products; medical research services in the field of immune repertoire analysis and the genome; scientific research in the fields of immunobiology, immunotherapy, antibodies and oncology; biological research; laboratory research services in the fields of immunobiology, immunotherapy, antibodies, oncology, and cellular engineering; medical laboratory services; providing information on medical and scientific research in the field of immunobiology and immunotherapy; medical and scientific research for others in the field of stem cell research, cancer, immunobiology and immunotherapy; compiling data for research purposes in the field of medical science and medical consultancy; medical and scientific research liaison services, namely, consulting in the field of scientific research pertaining to clinical trials in the fields of health care, medicine, immunobiology, immunotherapy, pharmacology and biotechnology; collection and management of medical and scientific data for research purposes in the field of medical and scientific research; Pharmaceutical research services; Pharmaceutical research services relating to cancer

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, January 11, 2023
Primary Code035
First Use Anywhere DateTuesday, November 14, 2023
First Use In Commerce DateTuesday, November 14, 2023

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, January 11, 2023
Primary Code036
First Use Anywhere DateMonday, September 30, 2024
First Use In Commerce DateMonday, September 30, 2024

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 11, 2023
Primary Code042
First Use Anywhere DateWednesday, July 19, 2023
First Use In Commerce DateWednesday, July 19, 2023

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 11, 2023
Primary Code044
First Use Anywhere DateMonday, September 30, 2024
First Use In Commerce DateMonday, September 30, 2024

Trademark Owner History


Party NameThe Board of Regents of the University of Texas System
Party Type20 - Owner at Publication
Legal Entity Type14 - State Agency
AddressAustin, TX 78701

Party NameThe Board of Regents of the University of Texas System
Party Type10 - Original Applicant
Legal Entity Type14 - State Agency
AddressAustin, TX 78701

Trademark Events


Event DateEvent Description
Tuesday, March 29, 2022NEW APPLICATION ENTERED
Wednesday, March 30, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 25, 2022ASSIGNED TO EXAMINER
Monday, August 29, 2022NON-FINAL ACTION WRITTEN
Monday, August 29, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 29, 2022NON-FINAL ACTION E-MAILED
Tuesday, November 1, 2022DIVISIONAL REQUEST RECEIVED
Tuesday, November 1, 2022TEAS REQUEST TO DIVIDE RECEIVED
Monday, December 5, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 12, 2022DIVISIONAL PROCESSING COMPLETE
Wednesday, January 11, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 11, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, January 11, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, January 11, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, January 17, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 21, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 18, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 11, 2023SOU TEAS EXTENSION RECEIVED
Friday, October 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 11, 2023SOU EXTENSION 1 FILED
Wednesday, October 11, 2023SOU EXTENSION 1 GRANTED
Thursday, April 11, 2024SOU EXTENSION 2 GRANTED
Thursday, April 11, 2024SOU TEAS EXTENSION RECEIVED
Thursday, April 11, 2024SOU EXTENSION 2 FILED
Friday, April 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 17, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 17, 2024SOU EXTENSION 3 FILED
Thursday, October 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 17, 2024SOU EXTENSION 3 GRANTED
Wednesday, April 23, 2025SOU EXTENSION 4 GRANTED
Wednesday, April 16, 2025SOU EXTENSION 4 FILED
Wednesday, April 16, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, April 23, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 5, 2025USE AMENDMENT FILED
Monday, May 5, 2025TEAS STATEMENT OF USE RECEIVED
Friday, May 9, 2025STATEMENT OF USE PROCESSING COMPLETE